Rohto Pharmaceutical Co.,Ltd. (RPHCF)
USD 21.54
(0.0%)
USD 21.54
(0.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 | 30.93 Billion JPY | 15481.77% |
| 2023 | 198.53 Million JPY | 14.39% |
| 2022 | 173.56 Million JPY | 14.55% |
| 2021 | 151.52 Million JPY | 6.15% |
| 2020 | 142.73 Million JPY | 61.21% |
| 2019 | 88.53 Million JPY | 1.37% |
| 2018 | 87.34 Million JPY | -2.78% |
| 2017 | 89.84 Million JPY | 10.99% |
| 2016 | 80.94 Million JPY | -99.06% |
| 2015 | 8.63 Billion JPY | -3.53% |
| 2014 | 8.94 Billion JPY | 10.63% |
| 2013 | 8.08 Billion JPY | -1.19% |
| 2012 | 8.18 Billion JPY | 2.74% |
| 2011 | 7.96 Billion JPY | 2.55% |
| 2010 | 7.76 Billion JPY | 26.54% |
| 2009 | 6.13 Billion JPY | -18.42% |
| 2008 | 7.52 Billion JPY | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 FY | 30.93 Billion JPY | 15481.77% |
| 2024 Q4 | 4.77 Billion JPY | 6951.48% |
| 2024 Q3 | 67.77 Million JPY | 34.96% |
| 2024 Q2 | 50.21 Million JPY | -20.27% |
| 2024 Q1 | 62.98 Million JPY | 76.57% |
| 2023 Q3 | 64.39 Million JPY | 50.42% |
| 2023 Q4 | 35.67 Million JPY | -44.6% |
| 2023 Q1 | 51.5 Million JPY | 53.48% |
| 2023 Q2 | 42.8 Million JPY | -16.88% |
| 2023 FY | 198.53 Million JPY | 14.39% |
| 2022 Q3 | 53.65 Million JPY | -0.89% |
| 2022 Q4 | 33.55 Million JPY | -37.45% |
| 2022 FY | 173.56 Million JPY | 14.55% |
| 2022 Q1 | 42.62 Million JPY | -16.77% |
| 2022 Q2 | 54.13 Million JPY | 27.01% |
| 2021 Q3 | 4.9 Billion JPY | 15.66% |
| 2021 Q2 | 4.24 Billion JPY | 142.76% |
| 2021 FY | 151.52 Million JPY | 6.15% |
| 2021 Q1 | 1.74 Billion JPY | -38.66% |
| 2021 Q4 | 51.21 Million JPY | -98.96% |
| 2020 FY | 142.73 Million JPY | 61.21% |
| 2020 Q3 | 5.25 Billion JPY | 3.32% |
| 2020 Q4 | 2.84 Billion JPY | -45.82% |
| 2020 Q1 | 2.21 Billion JPY | 306.81% |
| 2020 Q2 | 5.08 Billion JPY | 129.5% |
| 2019 Q4 | -1.07 Billion JPY | -130.16% |
| 2019 FY | 88.53 Million JPY | 1.37% |
| 2019 Q3 | 3.55 Billion JPY | -8.33% |
| 2019 Q2 | 3.87 Billion JPY | 12.7% |
| 2019 Q1 | 3.44 Billion JPY | 523.12% |
| 2018 Q2 | 3.37 Billion JPY | 48.22% |
| 2018 Q1 | 2.27 Billion JPY | 42.45% |
| 2018 FY | 87.34 Million JPY | -2.78% |
| 2018 Q4 | -813 Million JPY | -118.25% |
| 2018 Q3 | 4.45 Billion JPY | 32.12% |
| 2017 Q2 | 2.81 Billion JPY | 105.24% |
| 2017 FY | 89.84 Million JPY | 10.99% |
| 2017 Q1 | 1.37 Billion JPY | 6.35% |
| 2017 Q4 | 1.59 Billion JPY | -62.18% |
| 2017 Q3 | 4.22 Billion JPY | 49.86% |
| 2016 FY | 80.94 Million JPY | -99.06% |
| 2016 Q2 | 3.54 Billion JPY | 166.94% |
| 2016 Q4 | 1.29 Billion JPY | -56.0% |
| 2016 Q1 | 1.32 Billion JPY | -52.3% |
| 2016 Q3 | 2.93 Billion JPY | -17.24% |
| 2015 Q4 | 2.78 Billion JPY | 22.7% |
| 2015 Q2 | 2.93 Billion JPY | 352.16% |
| 2015 Q1 | 648 Million JPY | -14.85% |
| 2015 Q3 | 2.26 Billion JPY | -22.56% |
| 2015 FY | 8.63 Billion JPY | -3.53% |
| 2014 Q4 | 761 Million JPY | -79.22% |
| 2014 FY | 8.94 Billion JPY | 10.63% |
| 2014 Q3 | 3.66 Billion JPY | 40.67% |
| 2014 Q2 | 2.6 Billion JPY | 35.7% |
| 2014 Q1 | 1.91 Billion JPY | 92.48% |
| 2013 Q1 | 1.74 Billion JPY | 49.36% |
| 2013 Q2 | 1.7 Billion JPY | -2.52% |
| 2013 Q3 | 3.64 Billion JPY | 113.98% |
| 2013 FY | 8.08 Billion JPY | -1.19% |
| 2013 Q4 | 997 Million JPY | -72.62% |
| 2012 FY | 8.18 Billion JPY | 2.74% |
| 2012 Q1 | 1.98 Billion JPY | 48.51% |
| 2012 Q2 | 2.09 Billion JPY | 5.18% |
| 2012 Q3 | 2.93 Billion JPY | 40.57% |
| 2012 Q4 | 1.16 Billion JPY | -60.21% |
| 2011 Q1 | 1.31 Billion JPY | -38.33% |
| 2011 Q4 | 1.33 Billion JPY | -55.71% |
| 2011 Q3 | 3.02 Billion JPY | 31.69% |
| 2011 Q2 | 2.29 Billion JPY | 74.98% |
| 2011 FY | 7.96 Billion JPY | 2.55% |
| 2010 Q1 | 1.84 Billion JPY | 29.28% |
| 2010 FY | 7.76 Billion JPY | 26.54% |
| 2010 Q4 | 2.12 Billion JPY | -16.37% |
| 2010 Q3 | 2.54 Billion JPY | 102.07% |
| 2010 Q2 | 1.25 Billion JPY | -31.67% |
| 2009 Q2 | 1.68 Billion JPY | 0.0% |
| 2009 FY | 6.13 Billion JPY | -18.42% |
| 2009 Q4 | 1.42 Billion JPY | -27.46% |
| 2009 Q3 | 1.96 Billion JPY | 16.71% |
| 2008 FY | 7.52 Billion JPY | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Science to Consumers, Inc. | - USD | -Infinity% |
| Bemax Inc. | -90.63 Thousand USD | 34131856.347% |
| Bruush Oral Care Inc. | -8.76 Million USD | 353038.318% |
| CCA Industries, Inc. | -422.86 Thousand USD | 7315892.71% |
| DSwiss, Inc. | -49.53 Thousand USD | 62452911.144% |
| EOS, Inc. | -627.15 Thousand USD | 4932859.737% |
| Greyson International, Inc. | -75.94 Thousand USD | 40735915.019% |
| Happy Town Holdings Inc. | - USD | -Infinity% |
| Horrison Resources Inc. | 120 Thousand USD | -25779900.0% |
| Infusion Brands International, Inc. | -6.94 Million USD | 445580.93% |
| Mandom Corporation | 17.18 Million USD | -179919.479% |
| Naples Soap Company Inc. | - USD | -Infinity% |
| Emo Capital Corp. | -597.89 Thousand USD | 5174261.306% |
| Oliveda International, Inc. | -1.3 Million USD | 2362425.58% |
| PacificHealth Laboratories, Inc. | -486.31 Thousand USD | 6361461.351% |
| Prosperous Future Holdings Limited | -4.96 Million USD | 623525.742% |
| PURE Bioscience, Inc. | -3.35 Million USD | 923562.687% |
| PayChest, Inc. | - USD | -Infinity% |
| Skinvisible, Inc. | -2.38 Million USD | 1298600.697% |
| Sentient Brands Holdings Inc. | -477.73 Thousand USD | 6475670.087% |
| Sunset Capital Assets, Inc. | -252.33 Thousand USD | 12259846.847% |
| The Stephan Co. | -83 Thousand USD | 37272389.157% |
| Turner Valley Oil & Gas, Inc. | -300.05 Thousand USD | 10310072.372% |
| Winning Brands Corporation | -395.48 Thousand USD | 7822453.483% |
| Warpaint London PLC | 17.69 Million USD | -174744.591% |
| Zoono Group Limited | -5.6 Million USD | 552089.74% |
| Zurvita Holdings, Inc. | -435.23 Thousand USD | 7108033.24% |